Treatment of anxiety disorders

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31535

Patent

active

053710827

ABSTRACT:
The invention relates to the use of p-chloro-N-(2-morpholinoethyl)benzamide in the treatment of anxiety disorders, such as, panic disorders, social phobia and obsessive compulsive disorder,

REFERENCES:
patent: 4210754 (1980-07-01), Burkard et al.
patent: 4906626 (1990-08-01), Amrein et al.
Dowson, J. H., J. Neural Transm. Suppl., vol. 23, 1987, pp. 121-138.
Bechelli et al., Curr. Med. Res. Opin., vol. 11/suppl. 1, 1989, pp. 38-52.
Da Prada, et al., J. Pharmacol. Exp. Ther., 248:400-414 (1989).
Schoerlin, et al., Acta. Psychiatr. Scan. Suppl. 82(630):108-110 (1990).
Liebowitz, et al., Journal of Clinical Psychopharmacology, 6:2 pp. 93-98 (1986).
Noyes, et al., J. Clin. Psychiatry., vol. 51, pp. 24-30 (1990).
Liebowitz, et al., Acta Psychiatr. Scand., Suppl., vol. 82(360), pp. 29-34 (1990).
Liebowitz, et al., Psychiatry Research, 22:89-90 (1987).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of anxiety disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of anxiety disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety disorders will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-214608

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.